The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer
Clinical trial NCT03401827 · UNKNOWN
Trial details
- NCT number
- NCT03401827
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.